USFDA completes inspection at Alembic Pharma’s Bioequivalence facility

21 Aug 2019 Evaluate

US Food & Drug Administration (USFDA) has completed inspection at Alembic Pharmaceuticals’ Bioequivalence facility located at Vadodara. The agency had conducted inspection from August 12, 2019 to August 15, 2019 and from August 12, 2019 to August 20, 2019 for Bioequivalence Bioanalytical and Bioequivalence Clinical. There were no 483s issued by USFDA at the end of the inspection.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

942.05 -23.15 (-2.40%)
18-Apr-2024 13:32 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.85
Dr. Reddys Lab 6068.35
Cipla 1375.90
Zydus Lifesciences 943.80
Lupin 1616.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.